Personality Functioning in Inpatients With Eating Disorders: Association With Symptom Severity and Treatment Outcome.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Heinzmann Sophia, Etzler Sonja, Hartmann Armin, Klein Eva M, Herpertz Stephan, Pape Magdalena, Heinzmann Stanislav, Doering Stephan, Hofmann Tobias, Rose Matthias, Imbierowicz Katrin, Geiser Franziska, Bierling Antonie, Weidner Kerstin, Rademacher Jörg, Michalek Silke, Morawa Eva, Erim Yesim, Skoda Eva-Maria, Teufel Martin, Peters Eva Milena Johanne, Kruse Johannes, von Boetticher Dirk, Herrmann-Lingen Christoph, Noehre Mariel, de Zwaan Martina, Dinger Ulrike, Friederich Hans-Christoph, Niecke Alexander, Albus Christian, Zwerenz Rüdiger, Beutel Manfred, Roenneberg Casper, Henningsen Peter, Stein Barbara, Waller Christiane, Hake Karsten, Spitzer Carsten, Stengel Andreas, Zipfel Stephan, Weimer Katja, Gündel Harald, Kessler Henrik, Spieler Derek, Lahmann Claas, Zeeck Almut
Аннотация
METHOD: The sample consisted of 397 patients with EDs, treated in 19 university hospitals for Psychosomatic Medicine and Psychotherapy in Germany between 1/2019 and 12/2020. PF was measured with the Structure Questionnaire of the Operationalised Psychodynamic Diagnosis (OPD-SQ, short version), eating psychopathology with the ED examination questionnaire (EDE-Q). Outcome was defined as a change in the EDE-Q total score. We used Latent Change Score Modelling to analyse changes in ED pathology during treatment and a 1-year follow-up period.
RESULTS: A higher level of impairment in PF at admission correlated with more eating psychopathology and a less favourable outcome. Additionally, greater improvement in PF correlated with greater improvements in ED symptomatology at discharge.
CONCLUSION: Impairment in PF needs to be part of diagnostic assessments and should be considered an important treatment target for psychotherapeutic interventions.
TRIAL REGISTRATION: The MEPP study was registered in the German Clinical Trials Register (DRKS, www.drks.de; ID: DRKS00016412).